Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Update

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the recipient of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 900 shares, an increase of 800.0% from the January 31st total of 100 shares. Based on an average trading volume of 2,400 shares, the short-interest ratio is presently 0.4 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price Performance

Shares of HROWM stock traded up $0.26 during trading hours on Friday, reaching $26.70. 188 shares of the stock were exchanged, compared to its average volume of 2,839. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 12-month low of $25.30 and a 12-month high of $27.72. The company’s 50-day moving average price is $26.49 and its 200-day moving average price is $26.42.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Wednesday, January 15th were given a dividend of $0.7422 per share. This represents a $2.97 dividend on an annualized basis and a dividend yield of 11.12%. The ex-dividend date was Wednesday, January 15th.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.